《传染性病原体与癌症》（Infectious Agents and Cancer）是一份同行评审的开放获取医学期刊，专注于发表关于感染诱发恶性肿瘤的分子病理学、流行病学和转化研究。Infectious Agents and Cancer is a peer-reviewed open-access medical journal dedicated to publishing molecular, epidemiological, and translational research on infection-induced malignancies.
该期刊涵盖与已知及新兴致癌病毒、细菌和寄生虫病原体相关的基础、临床及公共卫生研究。The journal encompasses basic, clinical, and public health research related to both established and emerging carcinogenic viral, bacterial, and parasitic agents.
该期刊的学术范围聚焦于病原体引起人类恶性转化的机制及相关干预措施。The scope of the journal focuses on the mechanisms and interventions associated with malignant transformation driven by infectious agents.
核心研究主题包括致癌病毒如人乳头瘤病毒（HPV）、乙型和丙型肝炎病毒（HBV/HCV）、爱泼斯坦-巴尔病毒（EBV）以及卡波西肉瘤相关疱疹病毒（KSHV）的致病机制。Core topics include the oncogenic mechanisms of viruses such as human papillomavirus (HPV), hepatitis B and C viruses (HBV/HCV), Epstein–Barr virus (EBV), and Kaposi's sarcoma-associated herpesvirus (KSHV).
此外，该期刊还报道致癌细菌如幽门螺杆菌（Helicobacter pylori）和寄生虫如埃及血吸虫（Schistosoma haematobium）诱发的慢性炎症和肿瘤发生研究。Additionally, the journal covers chronic inflammation and tumorigenesis triggered by bacterial species such as Helicobacter pylori and parasitic infections like Schistosoma haematobium.
重点优先发表涵盖生物标志物鉴定、预防性疫苗研发、早期筛查策略以及靶向抗病毒或抗菌疗法的稿件。Priority is given to manuscripts covering biomarker discovery, prophylactic vaccine development, early screening strategies, and targeted antimicrobial therapeutics.
该期刊于2006年由BioMed Central（现隶属于Springer Nature）创刊推出。The journal was established in 2006 by BioMed Central, which is now part of Springer Nature.
创办该刊的初衷是为全球肿瘤学界和微生物学界提供一个跨学科的学术交流平台。It was founded to provide a dedicated interdisciplinary forum bridging oncology and microbiology for the global scientific community.
随着全球约15%至20%的癌症负担被证实与感染原直接相关，该期刊的研究成果在公共卫生与预防医学领域获得了持续的学术关注。As an estimated 15% to 20% of the worldwide cancer burden became recognized as attributable to infectious agents, the journal gained sustained recognition across public health and preventive medicine.
自创刊以来，该期刊被PubMed Central、Science Citation Index Expanded（SCIE）和Scopus等主要学术数据库收录。Since its inception, the journal has been indexed by major bibliographic databases, including PubMed Central, Science Citation Index Expanded (SCIE), and Scopus.
该期刊的创刊主编为弗朗哥·M·布纳古罗（Franco M. Buonaguro）教授，他长期任职于意大利那不勒斯帕斯卡尔国家癌症研究所分子生物学与病毒肿瘤学系。The founding Editor-in-Chief of the journal is Franco M. Buonaguro, affiliated with the Molecular Biology and Viral Oncology Unit at the National Cancer Institute Fondazione Pascale in Naples, Italy.
副主编及资深编辑团队包括来自国际癌症研究机构（IARC）和全球顶尖大学的病毒肿瘤学专家。The associate and senior editorial leadership includes prominent viral oncologists from institutions such as the International Agency for Research on Cancer (IARC) and leading international universities.
编辑委员会由跨越免疫学、流行病学、病理学及分子病毒学等多个学科领域的全球专家共同组成。The editorial board consists of international scholars spanning immunology, epidemiology, pathology, and molecular virology.